Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outlook Therapeutics (OTLK) Tax Rate (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Tax Rate for 5 consecutive years, with 20.69% as the latest value for Q3 2019.

  • On a quarterly basis, Tax Rate rose 1677.0% to 20.69% in Q3 2019 year-over-year; TTM through Sep 2025 was 4.54%, a N/A change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Tax Rate was 20.69% for Q3 2019 at Outlook Therapeutics, up from 3.92% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 62.13% in Q4 2017 to a low of 6.78% in Q3 2017.
  • A 5-year average of 7.71% and a median of 0.04% in 2015 define the central range for Tax Rate.
  • Peak YoY movement for Tax Rate: rose 29bps in 2016, then soared 6215bps in 2017.
  • Outlook Therapeutics' Tax Rate stood at 0.31% in 2015, then surged by 93bps to 0.02% in 2016, then soared by 296682bps to 62.13% in 2017, then tumbled by -94bps to 3.92% in 2018, then soared by 428bps to 20.69% in 2019.
  • Per Business Quant, the three most recent readings for OTLK's Tax Rate are 20.69% (Q3 2019), 3.92% (Q3 2018), and 62.13% (Q4 2017).